Accomplishments in 2008 in the management of localized gastric cancer.
作者信息
Okines Alicia, Bang Yung-Jue, Cunningham David
机构信息
The Royal Marsden Hospital NHS, Foundation Trust, Surrey, UK.
出版信息
Gastrointest Cancer Res. 2009 Sep;3(5 Supplement 2):S48-52.
Abstract
Overview of the Disease ProcessIncidencePrognostic or Predictive FactorsCurrent General Therapy StandardsSurgeryAdjuvant ChemoradiationPerioperative ChemotherapyAdjuvant Oral Fluoropyrimidine MonotherapyAccomplishments in 2008TherapyBiomarkers and Basic ScienceWhat Needs to Be DoneApplications of the AccomplishmentsControversies and DisagreementsSpecial PopulationsCurrent and Future DirectionsComments on ResearchObstacles to Progress.
摘要
相似文献
1
Accomplishments in 2008 in the management of localized gastric cancer.
Gastrointest Cancer Res. 2009 Sep;3(5 Supplement 2):S48-52.
2
Accomplishments in 2008 in the management of esophageal cancer.
Gastrointest Cancer Res. 2009 Sep;3(5 Supplement 2):S53-7.
3
Accomplishments in 2008 in the management of localized pancreatic cancer.
Gastrointest Cancer Res. 2009 Sep;3(5 Supplement 2):S37-42.
4
Accomplishments in 2008 in the management of advanced gastroesophageal cancer.
Gastrointest Cancer Res. 2009 Sep;3(5 Supplement 2):S58-61.
5
Accomplishments in 2007 in the management of advanced gastroesophageal cancer.
Gastrointest Cancer Res. 2008 May;2(3 Suppl):S47-50.
6
Accomplishments in 2007 in the management of localized pancreatic cancer.
Gastrointest Cancer Res. 2008 May;2(3 Suppl):S32-6.
7
Accomplishments in 2008 in the management of gastrointestinal stromal tumors.
Gastrointest Cancer Res. 2009 Sep;3(5 Supplement 2):S67-72.
8
Accomplishments in 2007 in the management of hepatobiliary cancers.
Gastrointest Cancer Res. 2008 May;2(3 Suppl):S25-31.
9
Accomplishments in 2007 in the treatment of advanced colorectal cancer.
Gastrointest Cancer Res. 2008 May;2(3 Suppl):S19-24.
10
Accomplishments in 2007 in the management of localized gastric cancer.
Gastrointest Cancer Res. 2008 May;2(3 Suppl):S42-6.
引用本文的文献
1
Characterization of lymph node metastasis and its clinical significance in the surgical treatment of gastric cancer.
Mol Clin Oncol. 2014 Sep;2(5):821-826. doi: 10.3892/mco.2014.303. Epub 2014 Jun 3.
本文引用的文献
1
Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer.
Ann Oncol. 2009 Sep;20(9):1529-1534. doi: 10.1093/annonc/mdp047. Epub 2009 May 27.
2
Impact of extended lymphadenectomy on morbidity, mortality, recurrence and 5-year survival after gastrectomy for cancer. Meta-analysis of randomized clinical trials.
Acta Cir Bras. 2008 Nov-Dec;23(6):520-30. doi: 10.1590/s0102-86502008000600009.
3
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Br J Cancer. 2008 Aug 19;99(4):584-90. doi: 10.1038/sj.bjc.6604536. Epub 2008 Jul 29.
4
Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.
J Natl Cancer Inst. 2008 Mar 19;100(6):388-98. doi: 10.1093/jnci/djn054. Epub 2008 Mar 11.
5
Cancer statistics, 2008.
CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96. doi: 10.3322/CA.2007.0010. Epub 2008 Feb 20.
6
Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s.
Eur J Cancer. 2008 Jul;44(10):1345-89. doi: 10.1016/j.ejca.2007.12.015. Epub 2008 Feb 14.
7
Capecitabine and oxaliplatin for advanced esophagogastric cancer.
N Engl J Med. 2008 Jan 3;358(1):36-46. doi: 10.1056/NEJMoa073149.
8
Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.
N Engl J Med. 2007 Nov 1;357(18):1810-20. doi: 10.1056/NEJMoa072252.
9
Estimates of the cancer incidence and mortality in Europe in 2006.
Ann Oncol. 2007 Mar;18(3):581-92. doi: 10.1093/annonc/mdl498. Epub 2007 Feb 7.
10
Gastric cancer: global pattern of the disease and an overview of environmental risk factors.
Best Pract Res Clin Gastroenterol. 2006;20(4):633-49. doi: 10.1016/j.bpg.2006.04.008.
Zotero 插件